Supreme Court Rejects Merck’s Bid to Reinstate $2.5B Damage Award Against Rival January 20, 2021 By Andrew Chung The U.S. Supreme Court on Tuesday rejected Merck & Co. Inc.’s bid to revive a $2.54 billion jury verdict it...
Appeals Court Reinstates Glaxo $235.5 Million Verdict Against Teva October 5, 2020 By Jonathan Stempel A federal appeals court on Friday reinstated a 2017 jury verdict ordering Teva Pharmaceutical Industries Ltd. to pay GlaxoSmithKline Plc...
Supreme Court Denies Drug Maker’s Use of Native American Tribe to Shield Patents April 16, 2019 By Lawrence Hurley The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc’s unorthodox bid to shield patents from a federal...
How to Keep Big Pharma from Winning Drug Price Wars: Joe Nocera April 9, 2019 By Joe Nocera, Bloomberg Opinion Robin Feldman is a law professor at the University of California Hastings with a particular expertise in antitrust and patent...
Lawmakers Cite Own Experiences in Grilling Drug Executives on Prices March 1, 2019 By Ricardo Alonso-Zaldivar and Matthew Perrone Channeling the ire of constituents and drawing from personal experience, senators chastised drug company executives Tuesday over the high cost...
Why Patent ‘Shenanigans’ Share Blame for High Cost of Drugs December 29, 2017 By Robert Langreth and Cynthia Koons Bob Kelsey can’t afford a cancer drug that could save his life. The retired firefighter, 53, needs Revlimid to stay...
Supreme Court to Hear Drugmakers’ ‘Pay for Delay’ of Generic Products Case March 22, 2013 By Diane Bartz The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic...